(MENAFN- GlobeNewsWire - Nasdaq)
DUBAI, United Arab Emirates, Feb. 02, 2023 (GLOBE NEWSWIRE) -- The hospital-acquired infection control market revenues were estimated at US$ 6.1 Bn in 2022 and is anticipated to grow at a CAGR of 7% from 2023-2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 12.7 Billion.
The frequent occurrence of hospital-acquired infections, the growing proportion of surgical procedures, the rising geriatric population and the increasing prevalence of chronic diseases, technological advancements in sterilization equipment, and the growing awareness of environmental and personal hygiene are the key factors driving the growth of the Hospital-acquired infection control market.
The growing use of e-beam sterilization and the reintroduction of ethylene oxide sterilization are further expected to swell the demand for hospital-acquired infection control.
Download Sample Copy@
The percentage of surgeries performed worldwide has increased significantly over the years. Every year, approximately 235 million complex surgical procedures are performed worldwide, according to the WHO. This is due to an increase in the prevalence of obesity and other lifestyle diseases, an increase in the geriatric population, and an increase in the incidence of spinal injuries and sports-related injuries.
With the growth in the number of surgical procedures conducted, the demand for various surgical equipment and medical devices is also surging. The proven benefits of sterilized product lines and growing awareness about their effectiveness in healthcare settings are expected to drive demand for hospital-acquired infection services.
Due to rising demand for Hospital-acquired Infection Control methods in developing nations, particularly Japan, the market in the Asia Pacific is projected to account for a CAGR of over 7% during the forecast period.
The regional market is growing due to the extensive usage of Hospital-acquired infection controls and increased awareness of general health and fitness among the working-class population.
Request for Report Customization@
The key players in the market include Steris Plc, Sotera Health Company, Getinge AB, Advanced Sterilization Products, Ecolab Inc., 3M Company, Matachana Group, MMM Group, Belimed AG, and Reckitt Benckiser.
Some of the recent developments of key Hospital-acquired Infection Control providers are as follows:
In 2021, STERIS purchased Cantel, a global provider of infection control products and services, through a U.S. subsidiary to broaden its vast array of sterilization services.
In 2021, Sterigenics S.A.S., a Sotera Health Company subsidiary, increased its European sterilizing capacity by expanding its ethylene oxide factory in Rantigny, France. Getinge introduced the Getinge Solsus 66 steam sterilizer for hospitals as well as surgical instruments in 2020, which has a higher capacity and operational reliability than other sterilizers.
In 2020, Sotera Health Company acquired Iotron, a prominent North American outsourced provider of E-beam sterilization services. The acquisition was intended to help the company expand its electron beam footprint and boost sales of the Sterigenics division.
Market Segments Covered in Hospital-acquired Infection Control Industry Analysis
Sterilization Equipment Disinfection Equipment
Disinfectants Sterilization Consumables Others (Waste Disposal, PPE)
By End- user :
Hospitals and Intensive Care Units Ambulatory Surgical and Diagnostic Centers Other End-users
Browse full Report@
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on District Cooling Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Million)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
More Insights Available
Future Market Insights, in its new offering, presents an unbiased analysis of the Hospital-acquired Infection Control Market, presenting historical market data (2018-2022) and forecast statistics for the period of 2023-2033.
The study reveals essential insights by Component (Equipment, Consumables, Services), by End- User (Hospitals and Intensive Care Units, Ambulatory Surgical and Diagnostic Centers, Other End-users) across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).
Ask an Analyst@
Explore FMI's related ongoing Coverage on Healthcare Market Insights Domain
hernia repair devices market size: The market for hernia repair devices is anticipated to be worth US$ 5.0 billion in 2023 and US$ 12.3 billion by 2033. During the projection period, sales of hernia repair devices are anticipated to grow significantly (CAGR: 9.4%).
antibody therapy market share: During the forecast period, the market for antibody treatment is anticipated to grow at a consistent CAGR of 13.4%. The market is expected to reach a value of US$ 824.0 billion by 2033.
venous ulcer treatment market demand: The market for treating venous ulcers is anticipated to reach US$ 2.96 million in 2023 and develop at a 6.5% compound annual growth rate (CAGR) from 2023 to 2033. The market is anticipated to reach US$ 7.61 billion at the conclusion of the previously mentioned forecast period.
surgical clips market trend: The market for surgical clips was valued at US$ 481.1 million in 2022 and is anticipated to expand at a 35.5% CAGR from 2023 to 2033. From 2023 to 2033, the market represented an absolute $12.3 billion opportunity.
surgical drapes market growth: The market for surgical drapes was worth over US$ 1.4 billion in 2022, and from 2023 to 2033, it is anticipated to expand at a compound annual growth rate (CAGR) of 4.2%.
About Future Market Insights (FMI)
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2023 on account of a high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.
Future Market Insights, Inc.
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
linkedin | twitter | blogs | youtube
For Sales Enquiries:
Tags hospital-acquired infection hospitals and intensive care infection control industry Related Links
postpartum depression management market helicobacter pylori testing market u.s. skilled nursing facility market photoacoustic tomography market hadron therapy market intracranial aneurysm market kidney stone extraction balloon market large volume wearable injectors market scoliosis management market thiamine market medical polyetheretherketone market surgical scissors market throat sprays market hemostasis products market chronic disease management market